Below we have provided links to a selection of OCRINT's more recent academic journal publications.
2023
Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001–2019) Imtiaz, S., Nigatu, Y. T., Sanches, M., Ali, F., Boak, A., Douglas, L., Hamilton, H. A., Rehm, J., Rueda, S., Schwartz, R. M., Wells, S., & Elton-Marshall, T.
Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study. Ali, F., Russell, C., Kaura, A., Leslie, P., Bayoumi, A. M., Hopkins, S., & Wells, S.
The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review. Russell, C., Law, J., Imtiaz., S. Rehm, J., Le Foll, B., Ali., F. .
Facts and analysis of Thailand’s cannabis policies: A public health perspective. Journal of Health Science, 32(2), 375-388. Sornpaisarn, B., Pipattanachat, V., Lamyai, W., Silawan, T., Dejkriengkraikul, N., Thitipraserth, W., & Rehm, J
Age, period and cohort effects on time trends in monthly cannabis use in adult population: 1996–2019 Nigatu, Y. T., Elton-Marshall, T., Rueda, S., Imtiaz, S., Hamilton, H. A
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study Ali, F., Kaura, A., Russell, C., Bonn, M., Bruneau, J., Dasgupta, N., Imtiaz, S., Martel-Laferrière, V., Rehm, J., Shahin, R. and Elton-Marshall, T.
“2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit Ali, F., Russell, C., Greer, A., Bonn, M., Werb, D., & Rehm, J.
Assessing data availability of NCD prevention and control in six ASEAN countries based on WHO global monitoring framework and the progress monitor indicators. Sornpaisarn, B., Limmade, Y., Pengpid, S., Jayasvasti, I., Chhoun, P., Somphet, V., Mustapha, F.I., Kaung, K.K., Chailek, C., Bao, T.Q. & Rehm, J.
Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001 – 2019) Imtiaz S, Yeshambel N, Ali F, Douglas L, Hamilton H, Rehm J Ruefa S, Schwartz R, Wells S, Elton-Marshall, T
Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Myran, D. T., Imtiaz, S., Konikoff, L., Douglas, L., Elton-Marshall, T.
Withdrawal management practices and services in Canada: A cross-national survey on the management of opioid use disorder. Ali, F., Russell, C., Law, J., Talbot, A., Elton-Marshall, T., Bozinoff, N., Imtiaz, S., Rehm, J., Giang, V., Rush, B.
2022
Methods and factors influencing successful smoking cessation in Thailand: A case-control study among smokers at the community level. Sornpaisarn, B., Parvez, N., Chatakan, W., Thitiprasert, W., Precha, P., Kongsakol, R., Saengow, U., & Rehm, J.
Essential and urgent policy and research and initial policy recommendations regarding the medical cannabis policy in Thailand. Sornpaisarn, B., Lamyai, W., Ratchadapunnathikul, C., Angkurawaranon, C., Dejkriengkraikul, N. & Rehm, J.
The Increase in Benzodiazepine-Laced Drugs and Related Risks in Canada: The Urgent Need for Effective and Sustainable Solutions. Russell, C., Law, J., Bonn, M., Rehm, J., Ali, F.
Opioid Agonist Treatment Take-Home Doses (‘Carries’): Are Current Guidelines Resulting in Low Treatment Coverage Among High-Risk Populations in Canada and the United States? Russell, C., Lange, S., Kouyoumdjian, F., Butler, A., Ali, F.
Applying the Socio-Ecological Model to Understand Community Reintegration Experiences among Individuals on Opioid Agonist Treatment (OAT) Released from Federal Incarceration in Ontario, Canada. Russell, C., Pang, M., Nafeh, F., Farrell MacDonald, S., Derkzen, D., Rehm, J., Fischer, B.
Youth substance use service provider’s perspectives on use and service access in Ontario: Time to reframe the discourse. Ali F, Russell C, Nafeh F, C Chaufan, Imtiaz S, Rehm J, Spafford A, Elton-Marshall T
Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: A repeated cross-sectional study from May 2020 to December 2020. Imtiaz, S., Wells, S., Rehm, J., Wickens, C. M., Hamilton, H. A., Nigatu, Y. T., Jankowicz, D., Elton-Marshall, T.
A national environmental scan of public withdrawal management services in Canada. Rush, B., Ali, F., Bozinoff, N., Talbot, A., Law, J., Elton-Marshall, T., Imtiaz, S., Giang, V., Rehm, J.
Cannabis use, increased cannabis use and cannabis use frequency in the context of the novel coronavirus disease (COVID-19) pandemic in Canada (May 2020 to March 2021) SImtiaz, S., Hamilton, H. A., Jankowicz, D., Nigatu, Y. T., Rehm, J., Wells, S., Wickens, C. M., Elton-Marshall, T.
2021
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada. Ali, F., Russell, C., Nafeh, F., Rehm, J., LeBlanc, S., & Elton-Marshall, T.
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study. Russell, C., Ali, F., Nafeh, F., Rehm, J., LeBlanc, S., & Elton-Marshall, T.
The longitudinal relationship between cannabis use and hypertension. Haleem, A., Hwang, Y. J., Elton‐Marshall, T., Rehm, J., & Imtiaz, S.
Prevalence and correlates of medicinal cannabis use among adolescents. Wardell, J. D., Rueda, S., Elton-Marshall, T., Mann, R. E., & Hamilton, H. A.
2020
Small communities, large oversight’: the impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada. Russell, C., Imtiaz, S., Ali, F., Elton-Marshall, T., & Rehm, J.
Major challenges in substance use research in Canada in 2019. Sornpaisarn, B., Ali, F., Elton-Marshall, T., Imtiaz, S., Probst, C., Sornpaisarn, S., & Rehm, J.
Recent changes in trends of opioid overdose deaths in North America. Imtiaz, S., Shield, K. D., Fischer, B., Elton-Marshall, T., Sornpaisarn, B., Probst, C., & Rehm, J.
Multiple COVID-19 risk factors increase the likelihood of experiencing anxiety symptoms in Canada. Elton-Marshall, T., Wells, S., Jankowicz, D., Nigatu, Y. T., Wickens, C. M., Rehm, J., & Hamilton, H. A.
2019
Responding to global stimulant use: challenges and opportunities. Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., ... & McKetin, R.
Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand? Rehm, J., Elton-Marshall, T., Sornpaisarn, B., & Manthey, J.
Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada. Russell, C., Neufeld, M., Sabioni, P., Varatharajan, T., Ali, F., Miles, S., ... & Rehm, J.
Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review. Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B.
Safer smoking kits for methamphetamine consumption. Imtiaz, S., Strike, C., Elton‐Marshall, T., & Rehm, J.
Alcohol use disorders. Carvalho, A. F., Heilig, M., Perez, A., Probst, C., & Rehm, J.
Global burden of alcohol use disorders and alcohol liver disease. Rehm, J., & Shield, K. D.